• Wolfram Steens, Wolfgang Zinser, Philip Rößler, and Thomas Heyse.
• Department of Orthopaedics, University Medicine, 18057, Rostock, Germany. dr.steens@onz-online.de.
• Arch Orthop Trauma Surg. 2024 Sep 1; 144 (9): 391339233913-3923.

AbstractGuideline-based surgical cartilage therapy for focal cartilage damage offers highly effective possibilities to sustainably reduce patients' complaints and to prevent or at least delay the development of early osteoarthritis. In the knee joint, it has the potential to reduce almost a quarter of the arthroses requiring joint replacement caused by cartilage damage. Biologically effective injection therapies could further improve these results. Based on the currently available literature and preclinical studies, intra- and postoperative injectables may have a positive effect of platelet-rich plasma/fibrin (PRP/PRF) and hyaluronic acid (HA) on cartilage regeneration and, in the case of HA injections, also on the clinical outcome can be assumed. The role of a combination therapy with use of intra-articular corticosteroids is lacking in the absence of adequate study data and cannot be defined yet. With regard to adipose tissue-based cell therapy, the current scientific data do not yet justify any recommendation for its use. Further studies also regarding application intervals, timing and differences in different joints are required.© 2023. The Author(s).

19 keywords...

hide…